| Literature DB >> 33968237 |
Barbara Verro1, Giuseppe Greco1, Enzo Chianetta1, Carmelo Saraniti1.
Abstract
Introduction Transoral laser microsurgery (TLM) is the treatment of choice for Tis-T2 squamous cell glottic carcinomas due to its advantages compared with open surgery and radiotherapy. However, the CO 2 laser beam causes changes and damage on the specimens, making the histological assessment of resection margins, the gold standard for confirming radical tumor resection, sometimes difficult. Objective To assess the different ways to manage patients depending on the status of the histopathological margin according to recent studies to detect the most commonly shared therapeutic strategy. Data Synthesis We analyzed the literature available on the PubMed and Web of Science databases, including only articles published since 2005, using specific keywords to retrieve articles whose titles and abstracts were read and analyzed independently by two authors to detect relevant studies. Therefore, we focused on disease-free survival, overall survival, local control, laryngeal preservation, and disease-specific survival. Thus, 17 studies were included in the present review; they were grouped according to the status of the histological margin, and we analyzed the different management policies described in them. This analysis showed that there is not a shared strategy, though in most studies the authors performed a second-look surgery in the cases of positive margins and a close follow-up in cases of negative ones. The main disagreement is regarding the management of close or non-valuable resection margins, since some some authors performed a second-look surgery, and others, a close follow-up. Conclusions Definitely, the most shared policy is the second-look surgery in case of positive surgical margins, and a close follow-up in case of close or non-valuable resection margins. Key Points To date, TLM is the treatment of choice for Tis-T2 squamous cell glottic carcinomas. The CO 2 laser beam could impair the histological assessment of the resection margins, which is the gold standard to confirm radical tumor resection. Second-look TLM is the most performed strategy in case of positive surgical margins.Close follow-up is the most shared policy in case of close or non-valuable resection margins.In cases of negative resection margins, follow-up represents the best approach. Fundação Otorrinolaringologia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. ( https://creativecommons.org/licenses/by-nc-nd/4.0/ ).Entities:
Keywords: glottic cancer; laser surgery; second-look surgery; squamous cell carcinoma; surgical margin
Year: 2020 PMID: 33968237 PMCID: PMC8096502 DOI: 10.1055/s-0040-1713922
Source DB: PubMed Journal: Int Arch Otorhinolaryngol ISSN: 1809-4864
Fig. 1Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2009 flow diagram of the selection process of studies in the current literature.
Overall characteristics of the studies included
| Authors | Number of patients | pT treated | Follow-up | OS | DSS | DFS | LP | LC |
|---|---|---|---|---|---|---|---|---|
|
| 79 | Tis-T1 | 56 months (mean) | / | 97.3% (5 years) | 89% (5 years) | 97.5% (5 years) | 95% (5 years) |
|
| 64 | T1a | 40 months (mean) | 97% (5 years) | / | 94% (5 years) | / | / |
|
| 84 | Tis-T1-T2 | 53 months (median) | 98.6% (5 years) | 78% (5 years) | / | 100% (5 years) | 78.6% (5 years) |
|
| 110 | T1-T2 | 43 months (mean) | 88% (5 years) | / | 73% (5 years) | / | 79% (5 years) |
|
| 96 | Tis-T1-T2 | 44.3 months (mean) | 79.2% (5 years) | 91.5% (5 years) | 61.7% (5 years) | 93.4% (5 years) | 74.4% (5 years) |
|
| 102 | T1-T2 | 48 months (median) | 100% (5 years) | / | 77.3% (5 years) | 100% (5 years) | / |
|
| 318 | Tis-T1-T2 | 58 months (median) | 90.01% (5 years) | / | 88.2% (8 years) | 97.1% (5 years) | / |
|
| 201 | Tis-T1-T2 | 50.82 months (mean) | 84.6% (5 years) | 96.2% (5 years) | 70.6% (5 years) | 96.8% (5 years) | 86.7% (5 years) |
|
| 55 | Tis-T1-T2 | 47 months (mean) | 96% (5 years) | / | 100% (5 years) | / | 91% (5 years) |
|
| 58 | T1-T2 | 43.1 months (mean) | 89.7% (3 years) | 98.3% (3 years) | / | 98.3% (3 years) | 96.5% (3 years) |
|
| 634 | Tis-T1-T2 | 60 months (median) | / | 98.3% (5 years) | 77.2% (5 years) | 96.2% (5 years) | / |
|
| 281 | T1-T2 | 51 months (median) | 91.4% (5 years) | 97.8% (3 years) | 84.7% (3 years) | / | / |
|
| 181 | T1-T2 | 59 months (mean) | 100% (5 years) | / | 96.3% (5 years) | / | / |
|
| 93 | Tis-T1-T2 | 75.6 months (median) | / | 96.8% | / | 96.8% (5 years) | 96.8% (5 years) |
|
| 72 | T1-T2 | 57.4 months (mean) | / | 98.6% (5 years) | 84.7% (5 years) | 97.2% (5 years) | / |
|
| 118 | T1-T2 | 69.36 months (mean) | 92.2% (5 years) | 99% (5 years) | 87.9% (5 years) | 96.2% (5 years) | 94.2% (5 years) |
|
| 177 | T1-T2 | 49.1 months (mean) | 90.8% (2 years) | 98.8% (2 years) | / | 97.6% (2 years) | 94.3 (2 years) |
Abbreviations: DFS, disease-free survival; DSS, disease-specific survival; LC, local control; LP, laryngeal preservation; OS, overall survival; pT, tumor stage.
Features of management of early glottic cancer in included studies
| Authors | Margin-to-tumor distance | Positive margins | Close or non- valuable margins | Negative margins | Suspicion on follow-up | Timing second look from first surgery | en bloc versus piecemeal excision | laser setting (watt, spot size) |
|---|---|---|---|---|---|---|---|---|
|
| 2 mm | close follow-up (++) or second look (+) according to surgeon's impressions | close follow-up (++) or second look (+) according to surgeon's impressions | follow-up | / | < 1 month | en bloc | / |
|
| / | second look (biopsies) | / | follow-up | / | 10 weeks | / | 7–12 weeks |
|
| / | close follow up (++) or second look (+) according to surgeon's impressions (biopsies) | follow-up | / | / | piecemeal | / | |
|
| 2 mm | close follow-up | / | follow-up | / | / | 5–10 weeks; 0.25 mm | |
|
| 0.5 mm | close follow-up | follow-up | second look | / | / | / | |
|
| 1 mm | second look | second look | follow-up | / | 3–4 weeks | / | / |
|
| 1 mm | if 1 margin: second look if > 1 margins: radiotherapy | second look | follow-up | / | / | en bloc | 0.8–4.7 weeks; 0,15 mm |
|
| 0.5 mm | follow-up | follow-up | follow-up | / | / | / | / |
|
| / | close follow-up with narrow-band imaging | / | follow-up | second look | / | / | / |
|
| / | second look | follow-up (second look only if high endoscopic suspicion) | follow-up | / | / | en bloc | 4–8 weeks |
|
| 1 mm | - 1 superficial margin: close follow-up - > 1 superficial margins: second look, open surgery or RT - deep margin: second look, open surgery or RT | close follow-up | follow-up | / | / | en bloc and piecemeal | / |
|
| 1 mm | - superficial margin: close follow-up - deep margin: second look or RT | close follow-up | follow-up | / | / | en bloc | 0.27 mm |
|
| / | second look (biopsy) | / | 8–10 weeks (fisrt second look 16–20 weeks (second second look) | en bloc | / | ||
|
| 3 mm | follow-up | second look | 3 months | / | / | ||
|
| 1 mm | - 1 superficial margin: close follow-up - deep margin: second look (revision) | follow-up | follow-up | / | / | en bloc and piecemeal | / |
|
| 0.5 mm | close follow-up (++) or second look (+) according to surgeon's impressions | / | follow up | / | / | en bloc and piecemeal | 1–2 w |
|
| 1 mm | - 1 superficial margin: close follow-up - > 1 superficial margins: second look (revision) - deep margin: second look (revision) | follow-up | follow-up | / | / | en bloc and piecemeal | / |